Overview

A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Study to Investigate The Pharmacokinetics of GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
GL Pharm Tech Corporation
Treatments:
Tamsulosin